CALGARY, AB — Nanalysis Scientific Corp. (the “Company” or “Nanalysis“) (TSXV: NSCI, FRA: 1N1) is pleased to announce the appointment of Philip Birkby as Interim Chief Financial Officer of the Company, effective October 5, 2026. Philip Birkby, CPA, CA, is a senior finance leader with more than 25 years of experience in publicly traded and private organizations, primarily in […]
WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that, effective today, Julie Sawyer Montgomery has assumed the roles of President and Chief Executive Officer and has joined Danaher’s Board of Directors, as previously announced on August 3, 2026. Since joining the Company in 2017, Ms. Sawyer Montgomery has held roles of increasing responsibility […]
THOUSAND OAKS, Calif. — Teledyne Technologies Incorporated (NYSE:TDY) announced today that Jason VanWees, Vice Chairman, will be retiring from his current position at Teledyne, effective February 1, 2027, at which point he will be age 55. Jason joined Teledyne prior to the company’s spin-off in 1999 and was named Vice Chairman in 2021. Mary Grace […]
Dr. Nimisha Srivastava Appointed Chief Executive Officer to Lead Slingshot Bio into Its Next Chapter
EMERYVILLE, Calif. — Slingshot Biosciences, a leader in precision-engineered cell mimics for flow cytometry, announced that Dr. Nimisha Srivastava has been appointed Chief Executive Officer, effective September 23, 2026. Dr. Srivastava previously served as the company’s Chief Operating Officer. Glenn Bilawsky will transition from his role as Chief Executive Officer. The Board of Directors thanks Glenn […]
ROCKVILLE, Md. — MaxCyte, Inc. (Nasdaq: MXCT), a leading cell engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it has appointed Sidharth Kapileshwar as Chief Corporate Development Officer. “Sidharth has a proven track record of building and scaling corporate development functions inside some […]
Former Olink Proteomics President brings extensive life-science tools leadership experience, having helped lead Olink through its $3.1 billion acquisition by Thermo Fisher Scientific Co-founder and former CEO Dr Michael Chen transitions to Chief Scientific and Business Officer Cambridge, UK, and Boston, MA, USA — Nuclera, the biotechnology company enabling access to innovative protein technologies, today announced […]
MARLBOROUGH, Mass. — Scitara, the Lab Connectivity and AI platform company serving the life sciences and biopharma industries, today announced a new strategic direction for the company alongside the appointment of Mike Tarselli, Ph.D., MBA, as Chief Strategy Officer. The moves mark Scitara’s evolution from a lab connectivity provider into a multi-vendor lab intelligence company. […]
REDWOOD CITY, Calif. — Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that David Horn, the Company’s President, Chief Financial Officer and Treasurer, will depart Seer effective October 1, 2026, to pursue a new opportunity at a private company. Charles Endweiss, who has […]
RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner will oversee the company’s global finance organization, including financial planning and analysis, accounting, treasury, […]
Lightcast Appoints Sarah Taylor as Vice President of Science Former 10x Genomics leader will help accelerate application development and commercial growth for Envisia™ single-cell analysis platform Cambridge, England – Lightcast,a pioneering life science tools company focused on functional single-cell analysis, today announced the appointment of Sarah Taylor, PhD, as Vice President of Science, effective immediately. She […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
